China Resources Sanjiu Traditional Chinese Medicine

China Resources Sanjiu Traditional Chinese Medicine is an insufficiently documented subject identified by the supplied name. The name appears to describe a traditional Chinese medicine brand or business area associated with China Resources Sanjiu, a Chinese healthcare company, but the available reference information does not establish whether “华润三九中药” is a legally independent company, a consumer-facing brand, a product portfolio, or an internal business designation. No reliable standalone website, founding date, headquarters, founder, ownership record, listing information, or authoritative encyclopedia entry was provided for the subject itself. Accordingly, this dossier does not attribute specific products, executives, campaigns, financial figures, market presence, or corporate events to the subject without source support. The name should be checked against official China Resources Sanjiu materials, product registrations, corporate filings, and Chinese-language business directories before it is treated as a distinct brand entry.

A reliable standalone history for China Resources Sanjiu Traditional Chinese Medicine could not be established from the supplied material. The subject name combines the China Resources Sanjiu identity with the traditional Chinese medicine category, but it does not by itself clarify the legal or commercial scope of the entity. It may denote a brand family, a traditional Chinese medicine business segment, or an informal description of products associated with China Resources Sanjiu. No verified chronology, incorporation record, founder, product launch history, ownership transition, or market expansion record has been identified for this exact name. Further research should distinguish the subject from China Resources Sanjiu Pharmaceutical Co., Ltd. and from individual traditional Chinese medicine products marketed under related corporate or product names. Until that distinction is confirmed, no milestones, campaigns, scandals, strategic decisions, or executive appointments can be safely assigned to this entry.

• 2015

  CR Sanjiu subsidiary recalls Shuxuening Injection, halts production and sales after sampling failure

  Securities Times reported that a sampling inspection on February 17, 2015 found two batches of Shuxuening Injection from China Resources Gaoke to be nonconforming. The company recalled the relevant batches and voluntarily expanded the recall, suspended production and sales of the product, and carried out risk assessment and rectification. The company said at the time that it had not received reports of serious adverse reactions. Progress: the company announcement confirmed the recall and suspension of production and sales. Entities involved: Beijing China Resources Gaoke Natural Medicine Co., Ltd.; China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Scope: under the original list, this is linked to the China Resources Sanjiu traditional Chinese medicine business name; the manufacturing company involved is Beijing China Resources Gaoke, not that business name being independently penalized.

  Source

Read more

1. 1CR Sanjiu subsidiary recalls Shuxuening Injection, halts production and sales after sampling failureepaper.stcn.com